GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RaQualia Pharma Inc (TSE:4579) » Definitions » Cyclically Adjusted Revenue per Share

RaQualia Pharma (TSE:4579) Cyclically Adjusted Revenue per Share : 円0.00 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is RaQualia Pharma Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

RaQualia Pharma's adjusted revenue per share for the three months ended in Dec. 2024 was 円0.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円0.00 for the trailing ten years ended in Dec. 2024.

During the past 12 months, RaQualia Pharma's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of RaQualia Pharma was 16.70% per year. The lowest was 16.70% per year. And the median was 16.70% per year.

As of today (2025-05-09), RaQualia Pharma's current stock price is 円437.00. RaQualia Pharma's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was 円0.00. RaQualia Pharma's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of RaQualia Pharma was 30.28. The lowest was 4.84. And the median was 15.17.


RaQualia Pharma Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for RaQualia Pharma's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaQualia Pharma Cyclically Adjusted Revenue per Share Chart

RaQualia Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.92 49.25 61.23 69.81 -

RaQualia Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.46 69.81 72.88 76.50 -

Competitive Comparison of RaQualia Pharma's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, RaQualia Pharma's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaQualia Pharma's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RaQualia Pharma's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where RaQualia Pharma's Cyclically Adjusted PS Ratio falls into.


;
;

RaQualia Pharma Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, RaQualia Pharma's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0/110.7000*110.7000
=0.000

Current CPI (Dec. 2024) = 110.7000.

RaQualia Pharma Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 2.411 97.900 2.726
201503 0.841 97.900 0.951
201506 2.188 98.400 2.462
201509 0.795 98.500 0.893
201512 4.661 98.100 5.260
201603 32.216 97.900 36.428
201606 0.666 98.100 0.752
201609 1.146 98.000 1.295
201612 3.551 98.400 3.995
201703 21.907 98.100 24.721
201706 2.378 98.500 2.673
201709 7.398 98.800 8.289
201712 40.068 99.400 44.623
201803 19.497 99.200 21.757
201806 2.427 99.200 2.708
201809 4.266 99.900 4.727
201812 10.384 99.700 11.530
201903 17.059 99.700 18.941
201906 9.572 99.800 10.617
201909 7.859 100.100 8.691
201912 47.485 100.500 52.304
202003 5.897 100.300 6.508
202006 11.894 99.900 13.180
202009 9.585 99.900 10.621
202012 25.475 99.300 28.400
202103 31.291 99.900 34.674
202106 31.742 99.500 35.315
202109 14.372 100.100 15.894
202112 55.027 100.100 60.854
202203 16.189 101.100 17.726
202206 52.825 101.800 57.443
202209 21.773 103.100 23.378
202212 48.248 104.100 51.307
202303 17.172 104.400 18.208
202306 29.772 105.200 31.329
202309 22.270 106.200 23.214
202312 18.763 106.800 19.448
202403 29.995 107.200 30.974
202406 35.237 108.200 36.051
202412 0.000 110.700 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


RaQualia Pharma  (TSE:4579) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of RaQualia Pharma was 30.28. The lowest was 4.84. And the median was 15.17.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


RaQualia Pharma Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of RaQualia Pharma's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


RaQualia Pharma Business Description

Industry
Traded in Other Exchanges
N/A
Address
5-2 Taketoyo, Aichi, Taketoyo, JPN, 470-2341
RaQualia Pharma Inc is engaged in the research and development of pharmaceutical compounds.

RaQualia Pharma Headlines

No Headlines